ArticleBMJ neurology open2024

Real-world efficacy, roll-out and uptake of intramuscular tixagevimab/cilgavimab as COVID-19 pre-exposure prophylaxis in people with multiple sclerosis and neuroimmunological conditions during the COVID-19 pandemic.

Louise Rath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.